pharmacie et médicaments – Pénurie de Repatha et Praluent alirocumab

This written question concerns the shortage of two cholesterol-lowering drugs, Repatha and Praluent, in France. It seeks information on the causes of these shortages and the measures being taken to address them. The question highlights the impact of these shortages on patients who rely on these medications for their treatment and asks about potential solutions to ensure a stable supply.